AbbVie Inc.
ABBV
$159.62
-$7.67-4.59%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 54.32B | 55.14B | 56.02B | 56.74B | 58.05B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 54.32B | 55.14B | 56.02B | 56.74B | 58.05B |
| Cost of Revenue | 18.92B | 18.78B | 17.31B | 17.25B | 17.30B |
| Gross Profit | 35.40B | 36.36B | 38.71B | 39.49B | 40.76B |
| SG&A Expenses | 12.90B | 12.45B | 12.36B | 12.30B | 12.18B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -10.00M | -11.00M | -11.00M | -11.00M | -1.00M |
| Total Operating Expenses | 39.48B | 38.75B | 37.08B | 36.83B | 35.97B |
| Operating Income | 14.84B | 16.39B | 18.95B | 19.91B | 22.09B |
| Income Before Tax | 6.25B | 8.00B | 10.45B | 9.02B | 13.48B |
| Income Tax Expenses | 1.38B | 1.48B | 1.76B | 1.43B | 1.63B |
| Earnings from Continuing Operations | 4.87K | 6.52K | 8.69K | 7.59K | 11.85K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -10.00M | -7.00M | -7.00M | -8.00M | -9.00M |
| Net Income | 4.86B | 6.51B | 8.69B | 7.59B | 11.84B |
| EBIT | 14.84B | 16.39B | 18.95B | 19.91B | 22.09B |
| EBITDA | 23.53B | 25.17B | 27.70B | 28.45B | 30.55B |
| EPS Basic | 2.73 | 3.65 | 4.87 | 4.25 | 6.65 |
| Normalized Basic EPS | 4.67 | 5.18 | 6.05 | 6.32 | 7.06 |
| EPS Diluted | 2.73 | 3.65 | 4.86 | 4.23 | 6.62 |
| Normalized Diluted EPS | 4.66 | 5.17 | 6.04 | 6.31 | 7.04 |
| Average Basic Shares Outstanding | 7.08B | 7.08B | 7.09B | 7.09B | 7.09B |
| Average Diluted Shares Outstanding | 7.09B | 7.10B | 7.10B | 7.11B | 7.11B |
| Dividend Per Share | 5.99 | 5.92 | 5.85 | 5.78 | 5.71 |
| Payout Ratio | 216.72% | 159.95% | 118.55% | 134.19% | 84.85% |
